The place of estramustine phosphate in the management of prostate cancer

dc.authorid0000-0002-8275-5479
dc.authorid0000-0002-3386-971
dc.contributor.authorÇam, Kamil
dc.contributor.authorYıldırım, Asıf
dc.contributor.authorÖzveri, Hakan
dc.contributor.authorAkdaş, Arif
dc.date.accessioned2021-06-23T18:54:42Z
dc.date.available2021-06-23T18:54:42Z
dc.date.issued2003
dc.departmentBAİBÜ, Tıp Fakültesi, Cerrahi Tıp Bilimlerien_US
dc.description.abstractEstramustine phosphate has been extensively used in the management of prostate cancer with distinct purposes that include primary treatment of metastatic prostate cancer and adjuvant or neoadjuvant applications in the localised cases. However, the most common clinical use is in the management of hormone refractory prostate cancer. Oral administration provides an important preference and also proven synergism with a number of chemotherapetic agents has caused utilisation in different combinations. The PSA response was documented between 30 to %60 in these studies. Gastrointestinal tract and cardiovascular toxicities are the main drawbacks. In conclusion, estramustine phosphate with respect to its easy administration as a hormonal and chemotherapeutic agent is one of the most common drugs used in the management of prostate cancer particularly in the case of hormone refractory disease.en_US
dc.description.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-0141559402&partnerID=40&md5=96b12878c512812eac0a97253d7a9655
dc.identifier.endpage170en_US
dc.identifier.issn1301-8825
dc.identifier.issue3en_US
dc.identifier.scopus2-s2.0-0141559402en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage165en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12491/4544
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-0141559402&partnerID=40&md5=96b12878c512812eac0a97253d7a9655
dc.identifier.volume13en_US
dc.indekslendigikaynakScopusen_US
dc.institutionauthorÇam, Kamil
dc.language.isotren_US
dc.relation.ispartofTHOD - Turk Hematoloji-Onkoloji Dergisien_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectEstramustine Phosphateen_US
dc.subjectProstate Canceren_US
dc.titleThe place of estramustine phosphate in the management of prostate canceren_US
dc.title.alternativeProstat kanseri tedavisinde estramustin fosfatin yerien_US
dc.typeReview Articleen_US
dcterms.temporalProstat kanseri tedavisinde estramustin fosfatin yeri

Dosyalar